Research Progress on Brucellosis

Author(s): Yuming Deng, Xinyue Liu, Kaifang Duan, Qisheng Peng*.

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 30 , 2019

Abstract:

Brucellosis is a debilitating febrile illness caused by an intracellular Brucella. The disease is distributed in humans and animals widely, especially in developing countries. Ten species are included in the genus Brucella nowadays; four species of them are pathogenic to humans, which make brucellosis a zoonosis with more than 500,000 new cases reported annually. For human brucellosis, the most pathogenic species is B. melitensis followed by B. suis, while B. abortus is the mildest type of brucellosis. The infection mechanism of Brucella is complicated and mostly relies on its virulence factors. The therapy of the disease contains vaccination and antibiotic. However, there are some defects in currently available vaccines such as the lower protective level and safety. Thus, safe and efficient vaccines for brucellosis are still awaited. The dual therapy of antibacterial is effective in the treatment of brucellosis if a rapid and exact detection method is found.

Keywords: Brucella, brucellosis, pathogen, treatment, febrile illness, genus, zoonosis.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 30
Year: 2019
Page: [5598 - 5608]
Pages: 11
DOI: 10.2174/0929867325666180510125009
Price: $58

Article Metrics

PDF: 21